Global Platelet Aggregation Devices Market 2017-2021

This market research study identifies F. Hoffmann-La Roche, Haemonetics, Helena Laboratories, Instrumentation Laboratory, and Siemens Healthineers as the leading players in the global platelet aggregation devices market. A comprehensive analysis of this market is also presented by product type (systems, reagents, and accessories and consumables), by end-users (hospital, diagnostic laboratories, and others), and by geography (the Americas, APAC, and EMEA).

Global platelet aggregation devices market forecast

According to platelet aggregation devices market analysis, the global platelet aggregation devices market will grow rapidly at a CAGR of more than 17% during the forecast period. The growing number of surgical procedures will be one of the key factors driving the market’s growth during the estimated period. Cardiovascular patients with impaired platelet function and are undergoing dual antiplatelet therapy are highly vulnerable to the risk of intra- and post-operative bleeding and transfusions. This drives the need to maintain a delicate balance between bleeding and clotting by monitoring the platelet function using platelet aggregation devices. Individuals who are undergoing coronary artery bypass graft (CABG) and percutaneous coronary intervention procedures should test for platelet function as recommended by clinical guidelines. These patients are treated with antiplatelet drugs such as aspirin and clopidogrel.

The Americas is witnessing an increasing number of surgeries and technological advancements in platelet aggregometer. Various companies that are engaged in the development, manufacture, and distribution of platelet aggregation devices are present in the US. The market will witness significant growth in this Americas due to the rising prevalence of target diseases such as cardiovascular, orthopedic, urological, and bleeding disorders.

Competitive landscape and key vendors

The platelet aggregation devices market is characterized by the presence of a few major vendors. These vendors are increasingly competing against each other based on factors such as technological advancements, strategic mergers and acquisitions, and partnerships, and R&D activities to attain maximum platelet aggregation devices market share. Additionally, they are also extensively taking efforts to expand their product portfolio by entering partnerships and collaborations. Several vendors are concentrating on gaining access to advanced technology and increasing their customer base by developing innovative products. Moreover, the vendors are also focusing on increasing their services, solutions, and manufacturing capabilities.

Key vendors in this market are 

• F. Hoffmann-La Roche
• Haemonetics
• Helena Laboratories
• Instrumentation Laboratory
• Siemens Healthineers

Other prominent vendors in the market include AggreDYNE, Bio/Data Corporation, Chrono-log Corporation, Drucker Diagnostics, LAbor BioMedical Technologies, Matis Medical, Sentinel Diagnostics, and Sysmex Corporation.

Segmentation by product type and analysis of the platelet aggregation devices market

• Systems
• Reagents
• Accessories and consumables

Platelet aggregation systems segment includes aggregometers, platelet function analyzers, flow cytometry, and platelet function centrifuge (PFC). The majority of revenue is generated from aggregometers. The demand for platelet aggregation systems was maximum during 2016 due to the technical advancement of products and the growing number of specialized laboratories and hospitals. The adoption of platelet aggregation systems will continue to increase in the forthcoming years due to the rising number of surgical procedures and the growing utilization of platelet aggregation devices in academic and pharmaceutical research for screening antiplatelet drug targets.

Segmentation by end-users and analysis of the platelet aggregation devices market

• Hospital
• Diagnostic laboratories

The hospital's segment accounted for the majority market share during 2016 due to the increasing number of hospitals in developing countries. The segment is witnessing an increased investment from the public and private sector for the development and modernization of healthcare infrastructure. The patient pool will continue to rely on hospitals over other health care centers due to the increasing application of platelet function tests in the evaluation of pre- and perioperative hemostasis and transfusion medicine.

Key questions answered in the report include

• What will the market size and the growth rate be in 2021?
• What are the key factors driving the global platelet aggregation devices market?
• What are the key market trends impacting the growth of the global platelet aggregation devices market?
• What are the challenges to market growth?
• Who are the key vendors in the global platelet aggregation devices market?
• What are the market opportunities and threats faced by the vendors in the global platelet aggregation devices market?
• What are the trending factors influencing the market shares of the Americas, APAC, and EMEA?
• What are the key outcomes of the five forces analysis of the global platelet aggregation devices market?

Technavio also offers customization on reports based on specific client requirement.